These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28655382)

  • 1. Novel clinical trial designs for targeted therapies
.
    Hsu Schmitz SF
    Int J Clin Pharmacol Ther; 2017 Aug; 55(8):695-697. PubMed ID: 28655382
    [No Abstract]   [Full Text] [Related]  

  • 2. New Clinical Trial Designs Hasten Approvals for Targeted Therapies.
    Schmidt C
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26944760
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trial designs incorporating predictive biomarkers.
    Renfro LA; Mallick H; An MW; Sargent DJ; Mandrekar SJ
    Cancer Treat Rev; 2016 Feb; 43():74-82. PubMed ID: 26827695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing a definitive trial for adjuvant targeted therapy in genotype defined lung cancer: the ALCHEMIST trials.
    Alden RS; Mandrekar SJ; Oxnard GR
    Chin Clin Oncol; 2015 Sep; 4(3):37. PubMed ID: 26408304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials.
    Quant EC; Wen PY
    Neuroimaging Clin N Am; 2010 Aug; 20(3):425-48. PubMed ID: 20708556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction to special issue on biomarker-based clinical trial designs in oncology.
    Sargent DJ; Mandrekar S; Grothey A
    Chin Clin Oncol; 2015 Sep; 4(3):28. PubMed ID: 26408295
    [No Abstract]   [Full Text] [Related]  

  • 7. Improved strategies for designing lupus trials with targeted therapies: learning from 65 years of experience.
    Wallace DJ
    Lupus; 2016 Sep; 25(10):1141-9. PubMed ID: 27497258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Society of Clinical Oncology Developing First Clinical Trial.
    Brower V
    J Natl Cancer Inst; 2015 Nov; 107(11):djv356. PubMed ID: 26538625
    [No Abstract]   [Full Text] [Related]  

  • 9. An overview of the NCI precision medicine trials-NCI MATCH and MPACT.
    Do K; O'Sullivan Coyne G; Chen AP
    Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NCI-MATCH launch highlights new trial design in precision-medicine era.
    McNeil C
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142446
    [No Abstract]   [Full Text] [Related]  

  • 11. Reinventing clinical trials: a review of innovative biomarker trial designs in cancer therapies.
    Lin JA; He P
    Br Med Bull; 2015 Jun; 114(1):17-27. PubMed ID: 25921239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Master Protocol Concept.
    Redman MW; Allegra CJ
    Semin Oncol; 2015 Oct; 42(5):724-30. PubMed ID: 26433553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding rare disease drug trials based on shared molecular etiology.
    Brooks PJ; Tagle DA; Groft S
    Nat Biotechnol; 2014 Jun; 32(6):515-8. PubMed ID: 24911489
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecularly targeted therapies for colorectal cancer: Strategies for implementing translational research in clinical trials.
    Zwierzina H; Bardelli A; Ciardiello F; Gariboldi M; HĂ„kansson L; Lambrechts D; Lind GE; Loeffler-Ragg J; Schmoll H; Siena S; Tabernero J; Van Cutsem E
    Curr Opin Mol Ther; 2010 Dec; 12(6):703-11. PubMed ID: 21154162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of the design and conduct of the BATTLE trials.
    Liu S; Lee JJ
    Chin Clin Oncol; 2015 Sep; 4(3):33. PubMed ID: 26408300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic research advances pancreatic cancer's early detection and treatment.
    Brower V
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142448
    [No Abstract]   [Full Text] [Related]  

  • 17. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.
    Farwell MD; Clark AS; Mankoff DA
    JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adaptive designs for clinical trial].
    Li W; He SJ; Wang Y; Cheng XR; Jia X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Jun; 28(6):605-7. PubMed ID: 17939395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial designs--made to order.
    Andersen JS
    J Biopharm Stat; 1996 Nov; 6(4):515-22. PubMed ID: 8969983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives on the design of clinical trials for targeted therapies and immunotherapy in veterinary oncology.
    Marconato L; Buracco P; Aresu L
    Vet J; 2015 Aug; 205(2):238-43. PubMed ID: 25862396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.